Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) | RFA AG 24 015

Opportunity Information: Apply for RFA AG 24 015

The Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76, Clinical Trial Required) is a National Institute on Aging (NIA), NIH career development grant designed for early-stage physician investigators and other health professionals who are committed to aging research or aging-related diseases. The main purpose is to accelerate the transition of promising faculty into recognized leaders who can influence their specialty area and also contribute to the broader field of geriatrics and aging science. The FOA emphasizes both research growth and leadership development, aiming to position awardees to meaningfully shift scientific understanding, clinical practice, and ultimately health outcomes for older adults.

This opportunity is distinct from many other mentored K awards because it is not intended for researchers who are just beginning to build a track record. Applicants are expected to already have a foothold as faculty investigators and to have demonstrated the ability to compete successfully for research funding. Specifically, candidates must have received competitively awarded research support as a Program Director/Principal Investigator (PD/PI) at the faculty level, or otherwise shown that they have leveraged faculty-level research support to build an independent line of research. In addition to research readiness, applicants must show evidence of leadership potential or demonstrated leadership in clinical and/or research settings, reflecting the program’s focus on producing emerging leaders rather than trainees at an earlier stage.

As indicated by the title, this is a "clinical trial required" funding opportunity, meaning the proposed work is expected to include a clinical trial component consistent with NIH definitions and requirements for clinical trials. Applicants should anticipate that the application will need to address the additional expectations that come with clinical trials under NIH policy, such as appropriate trial design, oversight, and human subjects protections, aligned with the aims of improving health and care for older individuals.

Eligibility is broad at the organizational level and includes many common U.S.-based applicant types such as public and private institutions of higher education, state and local governments, eligible tribal governments and tribal organizations, independent school districts, special district governments, public housing authorities/Indian housing authorities, nonprofits (both with and without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses, among others. The FOA also highlights a range of other eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, foreign involvement is explicitly restricted: non-domestic (non-U.S.) entities and non-domestic (non-U.S.) components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.

Key administrative details provided in the source data include the funding opportunity number RFA-AG-24-015 and CFDA number 93.866, with NIH as the sponsoring agency and NIA as the institute leading the initiative. The original application closing date listed is October 18, 2024. The award ceiling shown is $225,000 (as presented in the provided data). The overall message of the announcement is that NIA is using this mechanism to recruit and advance early-stage, already-productive clinician-scientists and health professional researchers in aging, providing structured support to deepen their research programs and expand their leadership capacity in ways that can improve the health and care of older adults.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2023-02-27.
• Applicants must submit their applications by 2024-10-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $225,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AG 24 015

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: